MetaCap

Cumberland Pharmaceuticals (CPIX) vs NeOnc Technologies (NTHI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals (CPIX) has outperformed NeOnc Technologies (NTHI) over the past year, gaining 193.5% versus a loss of 46.2%. NeOnc Technologies is the larger company by market cap ($90.9 million vs $87.6 million), about 1.0 times the size, while Cumberland Pharmaceuticals is growing revenue faster (+17.6% vs -51.8%). Cumberland Pharmaceuticals converts more of its revenue into profit, with a net margin of -6.4% versus -155404.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+193.47%NTHI-46.25%
+371%+147%-77%
Nov 21, 20251 yearNov 20, 2026
CPIX+32.43%NTHI-80.97%
+101%+4%-92%
Mar 24, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus NTHI key metrics
MetricCPIXNTHI
Share price$5.84$3.15
Market cap$87.57M$90.88M
1-day change-7.30%-9.48%
YTD return+46.73%-61.91%
1-year return+193.47%-46.25%
5-year return+161.88%—
Forward P/E41.71—
EPS (TTM)$-0.57$-1.95
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M$39.99K
Revenue growth (YoY)+17.57%-51.82%
Net income (latest FY)$-2.84M$-62.15M
Gross margin85.02%—
Operating margin-6.27%-145637.52%
Net margin-6.37%-155404.38%
52-week high$9.28$11.38
52-week low$2.00$2.50
Distance from 52-week high-37.07%-72.31%
Analyst consensus—strong_buy
Avg. price target upside—+439.68%
Average volume114.52K187.23K
Shares outstanding15.00M28.85M
Employees885
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CPIX has outperformed NTHI by 239.7 percentage points over the past year.
  • Cumberland Pharmaceuticals is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -155404.4 cents for NeOnc Technologies.
  • Cumberland Pharmaceuticals grew revenue faster in its latest fiscal year (+17.57% vs -51.82%).

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About NeOnc Technologies

NTHI stock →

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

CPIX vs NTHI FAQ

Which is bigger, Cumberland Pharmaceuticals or NeOnc Technologies?

NeOnc Technologies (NTHI) is larger, with a market capitalization of $90.88M compared with $87.57M for Cumberland Pharmaceuticals (CPIX).

Which stock has performed better over the past year, CPIX or NTHI?

CPIX returned +193.47% over the past 12 months, compared with -46.25% for NTHI (price return, excluding dividends). Past performance does not predict future results.

Are Cumberland Pharmaceuticals and NeOnc Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons